Ironwood Pharmaceuticals, Inc.
IRWD
$0.7267
-$0.0233-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -38.12% | 523.95% | 79.34% | -282.89% | -107.09% |
| Total Depreciation and Amortization | -46.53% | 755.66% | -79.34% | 0.20% | 0.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 188.66% | -30.01% | 51.50% | -66.51% | 110.29% |
| Change in Net Operating Assets | -216.11% | -193.21% | -66.03% | 492.94% | -80.05% |
| Cash from Operations | 53.91% | -70.46% | -25.61% | 25.54% | 10.40% |
| Capital Expenditure | 100.00% | 72.41% | 14.71% | 67.77% | -330.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 82.38% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 72.41% | 14.71% | 98.38% | 81.49% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 40.00% | 87.50% | -700.00% | 0.00% | 66.67% |
| Issuance of Common Stock | -- | -100.00% | -92.56% | 908.12% | 8,216.67% |
| Repurchase of Common Stock | -- | 100.00% | 80.36% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.83% | -- | -- | -- | -- |
| Cash from Financing | 45.18% | 45.00% | -217.40% | 69.44% | 32.12% |
| Foreign Exchange rate Adjustments | 180.77% | 49.02% | -312.50% | 148.00% | -1,566.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.01% | -8.10% | -154.50% | 252.20% | 70.37% |